Rafii, S., Roda, D., Geuna, E., Jimenez, B., Rihawi, K., Capelan, M., . . . Banerji, U. (2015). Higher risk of infections with PI3K-AKT-mTOR pathway inhibitors in patients with advanced solid tumors on Phase I clinical trials. Clin Cancer Res.
Citação norma ChicagoRafii, Saeed, et al. "Higher Risk of Infections With PI3K-AKT-mTOR Pathway Inhibitors in Patients With Advanced Solid Tumors On Phase I Clinical Trials." Clin Cancer Res 2015.
Citação norma MLARafii, Saeed, et al. "Higher Risk of Infections With PI3K-AKT-mTOR Pathway Inhibitors in Patients With Advanced Solid Tumors On Phase I Clinical Trials." Clin Cancer Res 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.